Form 4 for VCYT VERACYTE, INC.

Accepted 2026-09-04 19:54:02 ET · period of report 2026-09-02 · accession 0001914620-26-000013 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
T	2026-09-04 19:54	2026-09-02	VCYT	McGuire Annie	EVP, GC	F - Tax	$44.88	-3,215	134.4K	-2%	-$144.3K
MT	2026-09-04 19:54	2026-09-04	VCYT	McGuire Annie	EVP, GC	S - Sale	$43.09	-3,254	131.2K	-2%	-$140.2K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-09-02	F	D	3,215	$44.88	134,414	D	—	—	(F1) Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale. (F2) Includes 389 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
2	Common	Common Stock	2026-09-04	S	D	2,154	$42.79	132,260	D	—	—	(F3) The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. (F4) Represents weighted average sales price. Sale prices for the transactions range from $42.49 to $43.38. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
3	Common	Common Stock	2026-09-04	S	D	1,100	$43.67	131,160	D	—	—	(F3) The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025. (F5) Represents weighted average sales price. Sale prices for the transactions range from $43.50 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.